Dysphagia Knowledge Hub — 吞嚥困難知識庫

Sarcopenic Dysphagia: Diagnosis, Resistance Training, and Protein Targets in Older Adults

Sarcopenic dysphagia is a relatively recently formalised clinical concept — the recognition that swallowing impairment can arise primarily from whole-body skeletal muscle loss (sarcopenia) rather than from a discrete neurological or structural pathology. The term was systematically introduced in the literature by Wakabayashi and Matsushima in 2016 and has since attracted growing research attention, particularly in geriatric medicine and rehabilitation sciences.

The concept matters clinically because sarcopenic dysphagia has a different therapeutic target than neurological dysphagia. In stroke-related or PD-related dysphagia, treatment focuses on neurological rehabilitation or compensatory strategies. In sarcopenic dysphagia, the primary intervention is addressing the underlying muscle deficit — through resistance exercise and nutritional support — alongside swallowing-specific rehabilitation. Treating only the swallowing without addressing the systemic sarcopenia is insufficient.

The Emerging Concept: Sarcopenia Meets Swallowing

Sarcopenia is defined by the European Working Group on Sarcopenia in Older People (EWGSOP2, 2019) as a progressive and generalised skeletal muscle disorder associated with adverse outcomes including falls, disability, hospitalisation, and mortality. Its diagnosis requires:

Low muscle strength (assessed by handgrip dynamometry: <27 kg men, <16 kg women, per EWGSOP2 thresholds)
Low muscle quantity or quality (assessed by DXA, BIA, or CT: appendicular lean mass index <7.0 kg/m² in men, <5.5 kg/m² in women)
Low physical performance (assessed by gait speed, Short Physical Performance Battery, or Timed Up and Go)

Sarcopenic dysphagia extends this framework to the swallowing musculature — principally the tongue, suprahyoid muscles, pharyngeal constrictors, and laryngeal muscles. These muscles are not exempt from the systemic sarcopenic process. Age-related reduction in tongue pressure, hyolaryngeal movement amplitude, and pharyngeal constrictor strength has been demonstrated in multiple cross-sectional studies and correlates with measures of systemic muscle mass.

The key question that defines sarcopenic dysphagia — distinguishing it from coincidental coexistence of sarcopenia and dysphagia from another cause — is whether the dysphagia is primarily attributable to the sarcopenic muscle loss rather than to a discrete neurological or structural lesion.

Diagnostic Criteria

A consensus diagnostic framework for sarcopenic dysphagia has been proposed by the Sarcopenic Dysphagia Working Group (Fujishima et al., 2019), adapted from the Japanese Society of Dysphagia Rehabilitation:

Definite sarcopenic dysphagia:

Dysphagia confirmed by clinical examination or instrumental assessment (VFSS or FEES)
Whole-body sarcopenia confirmed by EWGSOP2 (or Asian Working Group for Sarcopenia — AWGS — criteria in East Asian populations)
Swallowing muscle mass reduction confirmed on imaging (CT or ultrasound of tongue and suprahyoid muscles)
No other identifiable cause of dysphagia

Probable sarcopenic dysphagia:

Dysphagia confirmed by clinical or instrumental assessment
Whole-body sarcopenia confirmed
No other identifiable cause of dysphagia
(Swallowing muscle imaging not available or not performed)

Possible sarcopenic dysphagia:

Dysphagia confirmed
Either whole-body sarcopenia or swallowing muscle atrophy (but not both confirmed)
No other identifiable cause of dysphagia

Asian-specific thresholds: The Asian Working Group for Sarcopenia (AWGS 2019) uses lower thresholds than EWGSOP2 (handgrip <28 kg men, <18 kg women; calf circumference <34 cm men, <33 cm women as a low-cost screening surrogate for muscle mass). These thresholds are more appropriate for patients from East and Southeast Asian backgrounds.

Tongue pressure as a diagnostic parameter: The Iowa Oral Performance Instrument (IOPI) and similar devices measure maximum isometric tongue pressure. Normal values in young adults are approximately 50–60 kPa; values below 30 kPa are associated with swallowing impairment. Tongue pressure below 20–24 kPa is used in some research frameworks as a criterion supporting swallowing muscle atrophy in the absence of imaging.

Who Is at Risk?

Sarcopenic dysphagia predominantly affects older adults with risk factors for systemic muscle loss:

Age: Sarcopenia prevalence rises sharply after 65 years, with rates of 10–29% in community-dwelling older adults and higher in hospitalised or institutionalised populations.
Prolonged hospitalisation and immobility: Acute illness causes rapid muscle loss — up to 1–2% of muscle mass per day of bed rest. A two-week hospitalisation can produce clinically significant new-onset sarcopenia in a previously borderline patient.
Malnutrition: Inadequate protein and energy intake is both a cause and a consequence of sarcopenia. The two conditions form a vicious cycle that is particularly prevalent in older adults with multiple comorbidities.
Chronic inflammatory conditions: Cancer, heart failure, COPD, and end-stage renal disease accelerate skeletal muscle catabolism through inflammatory mediators.
Pre-existing frailty: Frailty and sarcopenia overlap substantially; frail older adults are at significantly elevated risk of sarcopenic dysphagia.

Resistance Training as Treatment: The Evidence Base

Resistance exercise is the intervention with the strongest evidence base for reversing or attenuating sarcopenia in older adults. Its application to swallowing muscle rehabilitation in sarcopenic dysphagia is emerging, with a growing body of supporting evidence.

Systemic resistance training: Standard lower and upper limb resistance training programmes (two to three sessions per week, 2–3 sets of 8–12 repetitions at 60–80% of one-repetition maximum) produce significant gains in muscle mass, strength, and physical function in older adults. Improvements in systemic muscle mass translate to improved swallowing function in patients with sarcopenic dysphagia, supporting the concept that treating the whole-body sarcopenia is clinically meaningful for swallowing outcomes.

Swallowing-specific resistance exercises:

Shaker exercise (head lift exercise): The patient, lying supine, lifts the head to view their toes while keeping the shoulders flat — sustained for 60 seconds (three repetitions) and repeated in short isometric lifts (30 repetitions). The Shaker exercise strengthens the suprahyoid muscle group, improves hyolaryngeal elevation, and increases anterior displacement of the hyoid — all of which improve cricopharyngeal opening. Randomised controlled trials have demonstrated significant improvement in VFSS outcomes and reduction in aspiration in older adults with dysphagia.
Chin tuck against resistance (CTAR): The patient places a ball or hand under the chin and performs sustained chin tucks against the resistance — isometrically and isokinetically. CTAR activates the same suprahyoid muscles as the Shaker exercise with lower cardiovascular demand and is better tolerated by frailer patients. Compared head-to-head, CTAR produces similar or superior outcomes to the Shaker exercise with better completion rates.
Tongue strengthening exercises: Using an IOPI device or tongue depressor, patients perform maximum isometric tongue presses (tongue pressed to the hard palate for 3 seconds, 3 sets of 10 repetitions). Randomised trials in older adults with low tongue pressure demonstrate significant tongue pressure gains and improved swallowing function after 8 weeks of training.
Expiratory muscle strength training (EMST): Using a calibrated threshold device, patients exhale forcefully against resistance (50–75% of maximum expiratory pressure, 5 sets of 5 repetitions, 5 days per week). EMST primarily targets the suprahyoid muscles through the physiological coupling between expiratory muscle activation and swallowing musculature. Evidence in PD and stroke dysphagia is strong; evidence specifically in sarcopenic dysphagia is emerging.

Exercise intensity and frailty: In frail older adults, lower exercise intensities (40–60% of one-repetition maximum) still produce meaningful gains and may be more achievable. Supervised progressive resistance training — with a physiotherapist or exercise physiologist monitoring load progression — is more effective than unsupervised home exercise alone.

Protein Intake Targets

Adequate protein intake is essential for both prevention of sarcopenic dysphagia and as a component of treatment. Current evidence supports the following targets:

For older adults at risk of sarcopenia:

Minimum: 1.0–1.2 g protein per kilogram body weight per day (above the general adult RDA of 0.8 g/kg/day)
Optimal for active rehabilitation: 1.2–1.5 g/kg/day
In the context of acute illness or significant muscle loss: up to 2.0 g/kg/day is supported by evidence, subject to renal function

Protein distribution: Distributing protein intake across three to four meals per day — rather than concentrating it in one meal — maximises muscle protein synthesis throughout the day. A bolus of approximately 25–40 g high-quality protein per meal appears to saturate anabolic signalling; smaller or larger single doses are less efficient for muscle synthesis.

Protein quality: Leucine-rich proteins have the strongest anabolic stimulus. Animal-source proteins (dairy, eggs, meat, fish) have higher leucine content and bioavailability than most plant proteins. Whey protein supplements provide a high-leucine, easily absorbed protein source that is well-tolerated by older adults and can be mixed into texture-modified meals.

Practical application for dysphagia patients:

Fortify pureed and texture-modified foods with protein-dense additions: milk powder, soft tofu, Greek yoghurt, blended legumes, protein powder
Oral nutritional supplements (ONS) should be chosen for protein density (≥18 g per 200 mL serving), not solely caloric content
Dietitian involvement is essential — protein targets must be individualised based on body weight, renal function, and comorbidities

The Evidence Base: Where We Are in 2026

Sarcopenic dysphagia research has advanced substantially since 2016 but remains a maturing rather than mature field. Key evidence gaps:

No large multicentre randomised controlled trials have tested combined resistance training plus nutritional intervention specifically in sarcopenic dysphagia populations. Most evidence comes from observational studies, smaller trials, and extrapolation from sarcopenia and dysphagia literatures.
Diagnostic criteria are not yet universally standardised, creating heterogeneity in published prevalence estimates (ranging from 2% to over 30% in hospitalised older adults depending on criteria used).
Long-term outcomes data — particularly on aspiration pneumonia reduction and mortality benefit from treatment — are limited.

Despite these gaps, the growing body of evidence is sufficient to support integrating sarcopenia assessment into dysphagia evaluation in older adults, and to justify combined resistance exercise and nutritional intervention as first-line treatment when sarcopenic dysphagia is identified.

Key Takeaway

Sarcopenic dysphagia represents a distinct mechanistic category of swallowing impairment in older adults — one driven by whole-body muscle loss rather than discrete neurological pathology. Its management requires addressing the systemic sarcopenic process through resistance training and protein-targeted nutrition, alongside swallowing-specific exercises. Early identification using sarcopenia screening tools (handgrip, gait speed, calf circumference), tongue pressure measurement, and formal swallowing assessment allows treatment to begin before irreversible muscle loss has advanced.